 Westport, CT, July 07, 2021 GLOBE NEWSWIRE -- BioSig Technologies, Inc. Nasdaq: BSGM BioSig or the Company, a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the completion of its previously announced underwritten public offering of 2,500,000 shares of its common stock, 0.001 par value per share, at a price to the public of 4.00 per share. The gross proceeds to BioSig from this offering were 10 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by BioSig. 